These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. JuSpace: A tool for spatial correlation analyses of magnetic resonance imaging data with nuclear imaging derived neurotransmitter maps. Dukart J; Holiga S; Rullmann M; Lanzenberger R; Hawkins PCT; Mehta MA; Hesse S; Barthel H; Sabri O; Jech R; Eickhoff SB Hum Brain Mapp; 2021 Feb; 42(3):555-566. PubMed ID: 33079453 [TBL] [Abstract][Full Text] [Related]
7. Neuroimaging approaches to cognition in Parkinson's disease. Montaser-Kouhsari L; Young CB; Poston KL Prog Brain Res; 2022; 269(1):257-286. PubMed ID: 35248197 [TBL] [Abstract][Full Text] [Related]
8. Neuroimaging and transcranial ultrasonography in Parkinson's disease. Mehta SH; Morgan JC; Sethi KD Curr Neurol Neurosci Rep; 2008 Jul; 8(4):297-303. PubMed ID: 18590613 [TBL] [Abstract][Full Text] [Related]
9. The role of neuroimaging in Parkinson's disease. Bidesi NSR; Vang Andersen I; Windhorst AD; Shalgunov V; Herth MM J Neurochem; 2021 Nov; 159(4):660-689. PubMed ID: 34532856 [TBL] [Abstract][Full Text] [Related]
10. The role of biomarkers and imaging in Parkinson's disease. Algarni MA; Stoessl AJ Expert Rev Neurother; 2016; 16(2):187-203. PubMed ID: 26829357 [TBL] [Abstract][Full Text] [Related]
11. Longitudinal Progression Markers of Parkinson's Disease: Current View on Structural Imaging. Yang J; Burciu RG; Vaillancourt DE Curr Neurol Neurosci Rep; 2018 Oct; 18(12):83. PubMed ID: 30280267 [TBL] [Abstract][Full Text] [Related]
12. Radiotracers for imaging of Parkinson's disease. Abbasi Gharibkandi N; Hosseinimehr SJ Eur J Med Chem; 2019 Mar; 166():75-89. PubMed ID: 30685535 [TBL] [Abstract][Full Text] [Related]
13. The role of structural and functional imaging in parkinsonian states with a description of PET technology. Brooks DJ Semin Neurol; 2008 Sep; 28(4):435-45. PubMed ID: 18843572 [TBL] [Abstract][Full Text] [Related]
14. Neuroimaging in Parkinson's disease: from pathology to diagnosis. Stoessl AJ Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S55-9. PubMed ID: 22166455 [TBL] [Abstract][Full Text] [Related]
15. Emerging Neuroimaging Biomarkers Across Disease Stage in Parkinson Disease: A Review. Mitchell T; Lehéricy S; Chiu SY; Strafella AP; Stoessl AJ; Vaillancourt DE JAMA Neurol; 2021 Oct; 78(10):1262-1272. PubMed ID: 34459865 [TBL] [Abstract][Full Text] [Related]
16. Neuroimaging in Parkinson's disease. Au WL; Adams JR; Troiano A; Stoessl AJ J Neural Transm Suppl; 2006; (70):241-8. PubMed ID: 17017536 [TBL] [Abstract][Full Text] [Related]
17. Parkinson's disease: imaging update. de la Fuente-Fernández R; Stoessl AJ Curr Opin Neurol; 2002 Aug; 15(4):477-82. PubMed ID: 12151846 [TBL] [Abstract][Full Text] [Related]
18. Neuroimaging in Parkinson's disease: focus on substantia nigra and nigro-striatal projection. Frosini D; Cosottini M; Volterrani D; Ceravolo R Curr Opin Neurol; 2017 Aug; 30(4):416-426. PubMed ID: 28537985 [TBL] [Abstract][Full Text] [Related]
20. Imaging the Functional Neuroanatomy of Parkinson's Disease: Clinical Applications and Future Directions. Lauretani F; Longobucco Y; Ravazzoni G; Gallini E; Salvi M; Maggio M Int J Environ Res Public Health; 2021 Feb; 18(5):. PubMed ID: 33670940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]